169 Results (Page 3 of 7)
Mexico Markets Research Reports
Mexico Allergy Therapeutics Market Analysis
Mexico Allergy Therapeutics Market was valued at $348 Mn in 2022 and is estimated to reach $582 Mn in 2030, exhibiting a CAGR of 6.65% during the forecast period. The market for allergy treatment medications is expanding as a result of the rising incidence of allergic illnesses and associated health problems. The top leading pharmaceutical companies operating in the market are GlaxoSmithKline, Sanofi, Merck & Co., Novartis, Bayer, Johnson & Johnson, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International, Grupo farmacéutico Sanfer and Genomma Laboratorios.
Mexico Alcohol Addiction Therapeutics Market Analysis
The Mexico Alcohol Addiction Therapeutics Market is valued at around $11 Mn in 2022 and is projected to reach $18 Mn by 2030, exhibiting a CAGR of 6.55% during the forecast period. The market is fueled by drivers such as increasing prevalence, an increase in the efforts taken by the government to battle addiction, and the adoption of newer advanced technologies by the general population. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Mexico are Elli Lily, Roche, AbbVie, TEVA, Otsuka Pharmaceuticals, GlaxoSmithKline, Johnson & Jhonson, Viatris, Grupo Ferrer and Genomma, among various others
Mexico Cardiovascular Drugs Market Analysis
Mexico Cardiovascular Drug Market is at around $2.1 Bn in 2022 and is projected to reach $2.9 Bn in 2030, exhibiting a CAGR of 4.05% during the forecast period. Increased prevalence of disease, greater awareness, and strategic partnerships between pharmaceutical companies and healthcare providers are driving the market. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.
Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $50 Mn in 2022, and is predicted to grow at (CAGR) of 8.05% from 2023 to 2030, to US $92 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, rising demand for therapeutics, increased government funding initiatives, and other factors. The industry is primarily dominated by players such as Liomont, Novartis, Sanofi, Pfizer Inc, among other players.
Mexico Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Mexico Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $17 Mn in 2022, and is predicted to grow at a CAGR of 6.05% from 2023 to 2030, to US $26 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, government initiatives, and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Roche, Biogen, AstraZeneca, Janssen among others
Mexico Age-Related Macular Degeneration Therapeutics Market Analysis
The Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $162 Mn in 2022 and is predicted to grow at (CAGR) of 9.15% from 2023 to 2030, to US $326 Mn by 2030. The key drivers of this industry include the surge in the prevalence of age-related macular degeneration, technological advancements, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others.
Mexico Addiction Therapeutics Market Analysis
Mexico addiction therapeutics market was valued at $152 Mn in 2022 and is estimated to reach $263 Mn in 2030, exhibiting a CAGR of 7.15% during the forecast period. The development of the addiction treatment sector has been fuelled by increased public awareness brought about by anti-drug campaigns and encouraging government initiatives. Major players in the market, including Pfizer, Johnson & Johnson, Novartis, Bristol Myers Squibb, Merck, GlaxoSmithKline, Sanofi, AbbVie, Eli Lilly and Company, and Boehringer Ingelheim, are driving innovations in this field
Mexico Adult Malignant Glioma Therapeutics Market Analysis
The Mexico Adult Glioma Therapeutics Market is valued at around $33 Mn in 2022 and is projected to reach $66 Mn by 2030, exhibiting a CAGR of 9.15% during the forecast period. The market is expanding because of advances in current treatment technologies, rising glioma prevalence, particularly among the elderly, and government measures to expand healthcare coverage. Key players in the Mexico Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Novartis, Pfizer, AbbVie, Bausch Health, Oncoclínica, SteinCares etc.
Mexico Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Mexico Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Retail Pharmacy Market, offering unmatched value, accuracy, and expert insights.
Mexico Radiotherapy Market Analysis
By 2030, it is anticipated that the Mexico Radiotherapy Market will reach a value of $xx Mn from $104 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Mexico is dominated by a few domestic players such as Tecnologia en Radioterapia, Medical Plus, and Grupo Gamma. The radiotherapy market in Mexico is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Mexico Radiotherapy is increasing on account of the rise in cancer cases in the country.
Mexico Physiotherapy Market Analysis
This report presents a strategic analysis of the Mexico Physiotherapy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Physiotherapy Market, offering unmatched value, accuracy, and expert insights.
Mexico Pharmaceutical Market Analysis
This report presents a strategic analysis of the Mexico Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Pharmaceutical Market, offering unmatched value, accuracy, and expert insights.
Mexico Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico Oncology Therapeutics Market will reach a value of $5.3 Bn from $2.7 Bn in 2022, growing at a CAGR of 8.65% during 2022-30. The Oncology Therapeutics Market in Mexico is dominated by a few domestic pharmaceutical companies such as Laboratorios Pisa, Grupo Biotoscana, and Liomont. The Oncology Therapeutics Market in Mexico is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Mexico Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Mexico Insulin Market Analysis
This report presents a strategic analysis of the Mexico Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Insulin Market, offering unmatched value, accuracy, and expert insights.
Mexico ENT Devices Market Analysis
Mexico's ENT Devices Market is projected to grow from $350 Mn in 2022 to $550 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Mexico ENT devices market include ACI Medical, Gamma Medical Instruments, and LAB-MED.
Mexico ECG Equipments Market Analysis
Mexico's ECG Equipment Market is expected to witness growth from $134 Mn in 2022 to $239 Mn in 2030 with a CAGR of 7.55% for the forecasted year 2022-2030. A growing number of people in Mexico are reaching the age of 65 to retire as the country's population increases. To monitor and treat aging-related health issues like heart disease, this demographic trend is boosting demand for healthcare services and diagnostic instruments, particularly ECG equipment. The market is segmented by product type and by end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Mexico Dialysis Market Analysis
This report presents a strategic analysis of the Mexico Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Dialysis Market, offering unmatched value, accuracy, and expert insights.
Mexico Diabetes Therapeutics Market Analysis
Mexico's diabetes therapeutics market is expected to witness growth from $2.15 Bn in 2022 to $4.61 Bn in 2030 with a CAGR of 9.95% for the forecasted year 2022-30. Increasing urbanization in Mexico along with unhealthy lifestyle choices are leading to the rising prevalence of diabetes which can be considered the main market driver. The Mexico diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Farmaceutica Maypo, Fifarma, and AstraZeneca are the major players in the Mexico diabetes therapeutics market.
Mexico Dermatology Drugs Market Analysis
This report presents a strategic analysis of the Mexico Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Dermatology Drugs Market, offering unmatched value, accuracy, and expert insights.
Mexico Coronary Stents Market Analysis
Mexico's Coronary Stents Market is expected to witness growth from $170 Mn in 2022 to $250 Mn in 2030 with a CAGR of 5.00% for the forecasted year 2022-30. In Mexico, where the rate and frequency of heart failure are extremely high, it is a significant public health concern. This expands the market for coronary stents and other CAD treatments. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Mexico Contraceptive Devices Market Analysis
Mexico's Contraceptive Devices Market is expected to witness growth from $194 Mn in 2022 to $365 Mn in 2030 with a CAGR of 8.25% for the forecasted year 2022-30. In Mexico, the necessity for efficient family planning and the country's expanding population are driving up the need for contraceptive devices. The market is segmented by type and by gender. Some key players in this market include Laboratorios Grin, Probiomed, Industria Farmacéutica Andrómaco, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Mexico Cancer Immunotherapy Market Analysis
Mexico's cancer immunotherapy market is expected to witness growth from $1.68 Bn in 2022 to $2.97 Bn in 2030 with a CAGR of 7.3% for the forecasted year 2022-30. The rising prevalence of cancer in Mexico and the increased government funding to support immunotherapy in Mexico are driving the growth of the market. The Mexico cancer immunotherapy market is segmented by type, application, and end user. Monticello Drug, Zoetis, and Bristol-Myers Squibb are the major players in the Mexico cancer immunotherapy market.
Mexico Over The Counter (OTC) Pharmaceuticals Market Analysis
Mexico's over-the-counter (OTC) pharmaceuticals market size was valued at $2062.5 Mn in 2022 and is estimated to expand at a CAGR of 6.54% from 2022 to 2030 and will reach $3423.7 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
Mexico Medical Devices Market Analysis
This report presents a strategic analysis of the Mexico Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Medical Devices Market, offering unmatched value, accuracy, and expert insights.
Mexico Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Mexico Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Orphan Diseases Drugs Market, offering unmatched value, accuracy and expert insights.